Nanjing Leads Biolabs Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Apr '26 Apr 16, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Market Capitalization	18,541	10,143	-	-
Enterprise Value	17,130	9,977	-	-
Last Close Price	93.85	51.00	-	-
PS Ratio	94.00	51.42	-	-
PB Ratio	13.16	7.20	-	-
P/TBV Ratio	13.18	7.21	-	-
EV/Sales Ratio	86.84	50.58	-	-
Debt / Equity Ratio	0.22	0.22	1.00	-0.07
Net Debt / Equity Ratio	-1.00	-1.00	-1.02	0.30
Net Debt / EBITDA Ratio	7.27	7.27	1.08	1.15
Net Debt / FCF Ratio	-	-	2.24	1.37
Asset Turnover	0.14	0.14	-	-
Quick Ratio	3.08	3.08	1.35	0.25
Current Ratio	3.37	3.37	1.50	0.26
Return on Equity (ROE)	-27.61%	-27.61%	-	-
Return on Assets (ROA)	-9.92%	-9.92%	-30.59%	-
Return on Capital Employed (ROCE)	-15.20%	-15.20%	-100.80%	27.80%
Earnings Yield	-1.27%	-2.32%	-	-
Buyback Yield / Dilution	-16.10%	-16.10%	-3.56%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.